MFG
EW icon

Menard Financial Group’s Edwards Lifesciences EW Stock Holding History

Menard Financial Group’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-2,106
Closed -$248K – 96
2022
Q1 		$248K Sell
2,106
-31
-1% -$3.48K 0.24% 115
2021
Q4 		$277K Sell
2,137
-346
-14% -$40.4K 0.23% 118
2021
Q3 		$281K Sell
2,483
-21
-0.8% -$2.4K 0.25% 120
2021
Q2 		$259K Buy
+2,504
New +$236K 0.25% 122

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Menard Financial Group's EW Position: Q2 2022 in Review

Menard Financial Group sold out of Edwards Lifesciences (EW) in Q2 2022, closing a stake of 2,106 shares — an estimated $248K sold.

Menard Financial Group first reported a position in EW in Q2 2021 and held it in 4 quarters. The position peaked at $281K in Q3 2021. 1,272 funds tracked by Wall St. Rank hold EW as of Q2 2022.

  • Menard Financial Group reported no remaining Edwards Lifesciences position as of Q2 2022 after selling out during the quarter.
  • Menard Financial Group sold 2,106 Edwards Lifesciences shares in Q2 2022, an estimated $248K.
  • Menard Financial Group first reported a position in Edwards Lifesciences in Q2 2021 and held it in 4 quarters.
  • Menard Financial Group's Edwards Lifesciences position peaked at $281K in Q3 2021.
  • 1,272 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2022.

Based on Menard Financial Group's 13F filing for Q2 2022, filed 15 Aug 2022.